Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Vacuum switch and electrode assembly therefor
System and method for providing radio communication in a land mobile radio system
Method for manufacturing light emitting diodes
Wind energy system having a connection protection device
Method and apparatus for automatically controlling gas pressure for a plasma cutter
System and method of error reporting in a video distribution network
Electrical converter with variable capacitor
  Randomly Featured Patents
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
Remotely operable security deadbolt lock device with anti-theft manually operable release
Motion transmitting device
Dual steerable vehicle
Distributed computation in untrusted computing environments using distractive computational units
Sealed rechargeable battery
Expandable stents and method for making same
Semiconductor integrated circuit and system
Exhaust gas recirculation filtration system
Drug Delivery port endotracheal tube